Diarrhea: all 865 studies
Page 9 of 9. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.
- Rifaximin, Loperamide and the Combination to Treat Travelers' DiarrheaCompletedNCT00292344Phase 4
- Randomized Controlled Trial of Killed Oral Cholera Vaccine in KolkataCompletedNCT00289224Phase 3
- Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care SettingCompletedNCT00278746Not applicable
- Effectiveness of Adding Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care SettingCompletedNCT00278681Phase 1
- Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in AdultsCompletedNCT00276328Phase 4
- Impact of Zinc Supplementation in Low Birth Weight Infants on Severe Morbidity, Mortality and Zinc Status: A Randomized Controlled TrialCompletedNCT00272142Not applicable
- Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished ChildrenCompletedNCT00272116Not applicable
- Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 MonthsCompletedNCT00269542Not applicable
- Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel SyndromeCompletedNCT00269412Phase 2
- TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in ChildrenCompletedNCT00265369Phase 3
- Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.CompletedNCT00258401Not applicable
- Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of MilkCompletedNCT00255385Phase 3
- Study of Glutamine as Prophylaxis for Irinotecan Induced DiarrheaCompletedNCT00255229Phase 2
- Health Impact Study of Aquatabs in Tamale, GhanaCompletedNCT00252928Not applicable
- Introduction of Hypo-osmolar ORS for Routine UseCompletedNCT00244777Phase 4
- 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBSCompletedNCT00230581Phase 2
- Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) StudyCompletedNCT00228254Phase 4
- Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBSTerminatedNCT00219505Not applicable
- Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge StrainsCompletedNCT00198796Phase 1
- A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaCompletedNCT00196794Phase 3
- A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189813Phase 2
- Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD TreatmentCompletedNCT00182429Phase 3
- Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBSTerminatedNCT00179582Not applicable
- Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-DiarrheaTerminatedNCT00177775Phase 2/3
- Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid TumorsCompletedNCT00143533Phase 1
- Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBSCompletedNCT00142987Phase 4
- Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate ResistanceCompletedNCT00137657Phase 4
- HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or MalnutritionWithdrawnNCT00133562Phase 3
- Long-term Impact and Intervention for Diarrhea in BrazilStatus unknownNCT00133406Phase 3
- Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging StudyWithdrawnNCT00124865Phase 1
- Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency DepartmentCompletedNCT00120744Not applicable
- Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani InfantsCompletedNCT00118872Not applicable
- A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCompletedNCT00106509Phase 3
- A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedNCT00101725Phase 2
- Rifaximin Versus Placebo in the Prevention of Travelers' DiarrheaCompletedNCT00098384Phase 2
- OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)CompletedNCT00097422Phase 2
- N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00093353Phase 1
- Phase 1 meCS6 + LT(R192G) Vaccine StudyWithdrawnNCT00090688Phase 1
- Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
- Invaplex 50 Vaccine Dose-RangingCompletedNCT00082069Phase 1
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal CancerCompletedNCT00075868Phase 3
- Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyCompletedNCT00067561Phase 3
- Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyCompletedNCT00067457Phase 3
- A Trial of Tap Water Treatment in the ElderlyCompletedNCT00058942Not applicable
- STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced DiarrheaCompletedNCT00050635Phase 4
- Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving ChemotherapyCompletedNCT00048971
- A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerTerminatedNCT00040391Phase 2
- For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyTerminatedNCT00037180Phase 2
- Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal CancerTerminatedNCT00036517Phase 1/2
- A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated DiarrheaCompletedNCT00034294Phase 2
- Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisCompletedNCT00033605Phase 3
- The Healthy Life Choices Project in HIV-Positive PatientsCompletedNCT00017810Phase 2
- Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV PatientsCompletedNCT00010491Phase 2
- Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerTerminatedNCT00006269Phase 3
- Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation TherapyCompletedNCT00003825Phase 3
- Glutamine in Preventing Acute Diarrhea in Patients With Pelvic CancerCompletedNCT00003170Phase 3
- Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal CancerCompletedNCT00003057Phase 3
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) PatientsCompletedNCT00002408Phase 3
- A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.CompletedNCT00002253Not applicable
- A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related DiarrheaCompletedNCT00002252Not applicable
- Diethylhomospermine (DEHSPM) for Refractory AIDS-Related DiarrheaCompletedNCT00002121Phase 1
- Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind TrialCompletedNCT00002088Phase 2
- Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised PatientsCompletedNCT00002062Not applicable
- A Study of Letrazuril in the Treatment of AIDS-Related DiarrheaCompletedNCT00001018Phase 1
- A Study of Spiramycin in the Treatment of Patients With AIDS-Related DiarrheaCompletedNCT00000980Phase 1